Skip to main content
HCA
NYSE Life Sciences

HCA Slashes Profit Outlook as Uninsured Care Costs Surge; Shares Tumble 10%

Tom Rudovsky · Reported by Reuters
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$354
Mkt Cap
$86.682B
52W Low
$330
52W High
$556.52
52W Position info
7.3% above low
Off High info
36% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

HCA is trading near its 52-week low of $330 (7.3% above the low).

Summary

HCA cut its full-year EPS guidance to $28.7-$30.5 from $29.1-$31.5, citing rising uncompensated care as ACA subsidies expire. The company also narrowed its revenue forecast to $77B-$79.5B and cut its 2026 outlook amid sliding surgical volumes. Shares fell nearly 10% premarket. This follows a preliminary Q2 revenue beat of $20.23B, but the profit warning overshadows the top-line strength. Same-facility admissions rose 2.5%, yet inpatient and outpatient surgeries declined, signaling a shift toward lower-acuity care. The guidance cut reflects margin pressure from a growing uninsured population, a headwind likely to persist through the year.

At the time of this announcement, HCA was trading at $354.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $86.7B. The 52-week trading range was $330.00 to $556.52. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

HCA - Latest Insights

HCA
Nov 09, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $499.00
Real-time Price: $504.30 info
Change: +$5.30 (+1%) info
Market Cap: $104.248B info
HCA
Oct 29, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $478.08
Real-time Price: $504.30 info
Change: +$26.22 (+5%) info
Market Cap: $104.248B info
HCA
Oct 27, 2026, 1:11 PM EDT
Source: Benzinga
Importance Score:
8
Price at Filing: $443.28
Real-time Price: $504.30 info
Change: +$61.02 (+14%) info
Market Cap: $104.248B info
HCA
Oct 27, 2026, 7:17 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $485.00
Real-time Price: $504.30 info
Change: +$19.30 (+4%) info
Market Cap: $104.248B info
HCA
Oct 27, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $460.95
Real-time Price: $504.30 info
Change: +$43.35 (+9%) info
Market Cap: $104.248B info